REPLIGEN CORP Number of Operating Segments
REPLIGEN CORP (RGEN) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2025-08-07
- REPLIGEN CORP number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- REPLIGEN CORP number of operating segments for the quarter ending 2024-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- REPLIGEN CORP number of operating segments for the quarter ending 2023-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- REPLIGEN CORP number of operating segments for the quarter ending 2022-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- REPLIGEN CORP number of operating segments for fiscal 2023 was 1.00 Segment.
- REPLIGEN CORP number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- REPLIGEN CORP number of operating segments for fiscal 2018 was 1.00 Segment, a 0.00% change from fiscal 2017.
- REPLIGEN CORP number of operating segments for fiscal 2017 was 1.00 Segment, a 0.00% change from fiscal 2016.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-04-29 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-18 | |||
| 2024-06-30 | 1.00 Segment 10-Q/A · filed 2024-11-18 | |||
| 2024-03-31 | 1.00 Segment 10-Q/A · filed 2024-11-18 | |||
| 2023-12-31 | 1.00 Segment 10-K/A · filed 2024-11-18 | |||
| 2023-09-30 | 1.00 Segment 10-Q/A · filed 2024-11-18 | |||
| 2023-06-30 | 1.00 Segment 10-Q/A · filed 2024-11-18 | |||
| 2023-03-31 | 1.00 Segment 10-Q/A · filed 2024-11-18 | |||
| 2022-09-30 | 1.00 Segment 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | 1.00 Segment 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | 1.00 Segment 10-Q · filed 2022-04-27 | |||
| 2021-09-30 | 1.00 Segment 10-Q · filed 2021-10-28 | |||
| 2021-06-30 | 1.00 Segment 10-Q · filed 2021-07-27 | |||
| 2021-03-31 | 1.00 Segment 10-Q · filed 2021-05-04 | |||
| 2020-09-30 | 1.00 Segment 10-Q · filed 2020-11-05 | |||
| 2020-06-30 | 1.00 Segment 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | 1.00 Segment 10-Q · filed 2020-05-06 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-26 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-03-01 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | 1.00 Segment 10-K · filed 2018-02-22 | |||
| 2017-09-30 | 1.00 Segment 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 1.00 Segment 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | 1.00 Segment 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | 1.00 Segment 10-K · filed 2017-02-23 | |||
| 2016-09-30 | 1.00 Segment 10-Q · filed 2016-11-03 | |||
| 2016-06-30 | 1.00 Segment 10-Q · filed 2016-08-04 | |||
| 2016-03-31 | 1.00 Segment 10-Q · filed 2016-05-05 | |||
| 2015-12-31 | 1.00 Segment 10-K · filed 2016-02-25 | |||
| 2015-09-30 | 1.00 Segment 10-Q · filed 2015-11-05 | |||
| 2015-06-30 | 1.00 Segment 10-Q · filed 2015-08-06 | |||
| 2015-03-31 | 1.00 Segment 10-Q · filed 2015-05-08 | |||
| 2014-12-31 | 1.00 Segment 10-K · filed 2015-03-17 | |||
| 2014-09-30 | 1.00 Segment 10-Q · filed 2014-11-07 | |||
| 2014-06-30 | 1.00 Segment 10-Q · filed 2014-08-11 | |||
| 2014-03-31 | 1.00 Segment 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | 1.00 Segment 10-K · filed 2014-03-14 | |||
| 2013-09-30 | 1.00 Segment 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | 1.00 Segment 10-Q · filed 2013-08-07 | |||
| 2013-03-31 | 1.00 Segment 10-Q · filed 2013-05-07 | |||
| 2012-12-31 | 1.00 Segment 10-K · filed 2013-03-15 | |||
| 2012-09-30 | 1.00 Segment 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | 1.00 Segment 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |